The Patient Pain Questionnaire (PPQ)

Abstract

The Patient Pain Questionnaire (PPQ) is a 16-item multidimensional self-report assessment developed by Dr. Betty R. Ferrell and colleagues at the City of Hope Pain & Palliative Care Resource Center. Designed specifically for oncology, palliative care, and chronic illness settings, the PPQ evaluates two core dimensions critical to effective analgesic management: Knowledge regarding pain and its pharmacologic/non-pharmacologic treatment (9 items), and Experience of pain, distress, and perceived control (7 items). Respondents rate each statement using an ordinal scale ranging from 0 to 10, structured such that 0 reflects the most favorable or positive clinical outcome (e.g., accurate understanding, complete pain relief, absence of distress) and 10 indicates the most unfavorable outcome (e.g., severe misconceptions, intolerable pain, extreme distress). Psychometric evaluations demonstrate strong content validity (Content Validity Index, CVI = .95), acceptable internal consistency reliability (Cronbach’s alpha = .74), and stable test-retest reliability (r = .65). Factor analytic investigations confirm a bifactorial structure distinguishing cognitive-attitudinal misconceptions from subjective-affective pain experiences. The tool functions both as an epidemiological research instrument and as a diagnostic clinical screener that identifies patient-level barriers to pain management, guiding personalized psychoeducational interventions. Its open-access availability has facilitated wide adaptation across inpatient oncology, home hospice care, and nursing research worldwide.

Keywords

Patient Pain Questionnaire, PPQ, cancer pain management, pain knowledge, pain experience, oncology nursing, palliative care, opioid misconceptions, chronic pain assessment, psychoeducational intervention

Authors

The Patient Pain Questionnaire was created and validated by a multidisciplinary team of nursing scientists and clinical researchers at the City of Hope National Medical Center (Duarte, California), led by:

• Betty Rolling Ferrell, PhD, RN, FAAN, FPCN — Director and Professor, Division of Nursing Research and Education, Department of Population Sciences, City of Hope Comprehensive Cancer Center.
• Bruce A. Ferrell, MD — Professor of Medicine and Geriatrics, David Geffen School of Medicine at University of California, Los Angeles (UCLA).
• Michelle Rhiner, RN, MS, CNS — Clinical Nurse Specialist in Pain and Palliative Care, City of Hope Pain & Palliative Care Resource Center.
• Marcia Grant, RN, DNSc, FAAN — Professor Emerita and Research Scientist, City of Hope Comprehensive Cancer Center.

Institutional oversight and dissemination are coordinated via the City of Hope Pain & Palliative Care Resource Center.

Purpose

Unrelieved cancer pain remains one of the most debilitating sequelae of malignant disease, contributing directly to functional impairment, severe psychological distress, reduced health-related quality of life, and caregiver burden. Despite substantial advancements in pharmacotherapy and neurobiology, clinical audits routinely reveal that 30% to 50% of cancer patients receive inadequate analgesia. A major contributor to this treatment gap involves patient- and family-related cognitive barriers, including deep-seated fears of iatrogenic opioid addiction, fatal respiratory depression, drug tolerance, medication toxicity, and the cultural fatalism equating escalating pain with impending death.

The primary purpose of the Patient Pain Questionnaire is to provide an efficient, psychometrically sound metric that captures both the cognitive knowledge barriers and the subjective physical and affective experiences of individuals coping with cancer pain. Clinically, the instrument enables physicians, oncology nurse specialists, and palliative interdisciplinary teams to:

• Identify specific cognitive misconceptions regarding analgesic pharmacokinetics and scheduling (e.g., believing medications should only be consumed when pain is unbearable, or hoarding doses for terminal phases).
• Quantify the subjective intensity of pain over acute (current) and retrospective (past week) time horizons.
• Assess the emotional burden and distress pain causes not only to the individual but also to the primary family unit.
• Evaluate self-efficacy and perceived personal agency regarding pain control.
• Establish baseline benchmarks prior to administering nursing psychoeducational curricula and measure longitudinal learning gains.

In academic research, the PPQ serves as a reliable outcome measure for randomized controlled trials evaluating the efficacy of nursing-led pain education programs, outpatient home-care interventions, palliative consult services, and family-centered coping modules. Because the PPQ was developed concurrently with its caregiver-targeted analogue, the Family Pain Questionnaire (FPQ), it enables dyadic research methodologies examining congruence, communication discrepancies, and shared distress between patients and their informal caregivers.

Psychological Construct

The Patient Pain Questionnaire conceptualizes cancer pain not merely as a nociceptive sensory input, but as a complex psychological, behavioral, and existential construct consisting of two intertwined dimensions: Pain Knowledge and Pain Experience.

1. Pain Knowledge Dimension

The Knowledge subscale comprises 9 items evaluating cognitive schemata, health beliefs, and pharmacotherapeutic literacy regarding analgesia. Rather than testing esoteric pharmacology, the dimension focuses on high-impact cognitive barriers identified in palliative care literature:

• Beliefs About Pain Manageability: Evaluates whether the patient views cancer pain as inherently intractable or medically modifiable (e.g., “Cancer pain can be effectively relieved”).
• Addiction and Tolerance Misconceptions: Measures patient anxiety regarding physical dependence and psychological addiction (e.g., “Most cancer patients on pain medicines will become addicted…”) and the erroneous belief that analgesics must be withheld to preserve efficacy for the future (“It is important to give the lowest amount… to save larger doses for later”).
• Administration Modalities and Timing: Evaluates understanding of scheduled round-the-clock administration versus as-needed (PRN) dosing for chronic malignant pain, assessing awareness that prophylactic maintenance prevents severe breakthrough episodes.
• Complementary and Non-Pharmacologic Therapies: Measures open-mindedness toward, and awareness of, adjuvant multimodal modalities such as massage, thermotherapy, and relaxation techniques.
• Adverse Event Anxiety and Fear of Lethality: Captures disproportionate fears regarding respiratory depression and fatal systemic toxicity (e.g., “Pain medicines can be dangerous and can often interfere with breathing”).
• Prognostic Somatization: Assesses fatalistic cognitive associations between pain escalation and tumor metastasis (e.g., “If pain is worse, the cancer must be getting worse”), which frequently causes patients to hide pain symptoms from clinicians.

2. Pain Experience Dimension

The Experience subscale consists of 7 items measuring the phenomenological, affective, and relational impact of chronic pain on the patient’s daily life:

• Sensory Intensity: Evaluates sensory pain magnitude across two temporal frames—retrospective intensity over the preceding seven days and current instantaneous intensity.
• Therapeutic Relief: Evaluates the perceived percentage or degree of pain relief currently conferred by ongoing medical regimens.
• Affective Distress (Self): Measures the subjective psychological toll, suffering, and emotional anguish evoked by persistent pain.
• Perceived Family Distress: Assesses the interpersonal dimension of pain, specifically the patient’s perception of the emotional suffering their pain imposes on close family members. In oncology, vicarious guilt regarding family distress often leads patients to underreport their symptoms.
• Perceived Control and Self-Efficacy: Measures perceived behavioral control—a vital factor in health psychology that moderates depression, learned helplessness, and functional decline.
• Future Expectations: Evaluates anticipatory anxiety, optimism, or fatalistic dread regarding the future course of pain.

Theoretical Framework

The theoretical architecture of the PPQ is grounded in three converging paradigms: the Gate Control Theory of Pain, Bandura’s Social Cognitive Theory, and Ferrell’s own Multidimensional Model of Quality of Life in Chronic Illness.

1. The Gate Control and Neuromatrix Models

Formulated by Ronald Melzack and Patrick Wall, the Gate Control Theory posits that pain perception is not a linear readout of tissue damage, but rather a dynamic interaction governed by sensory-discriminative, motivational-affective, and cognitive-evaluative neural systems. Melzack’s subsequent Neuromatrix framework emphasizes that cognitive beliefs, cultural learning, and anticipated outcomes act via descending cortico-thalamic projections to open or close spinal gating mechanisms. The PPQ operationalizes these cognitive-evaluative inputs within its Knowledge dimension, recognizing that irrational fears of addiction or disease progression elevate autonomic arousal and lower pain thresholds.

2. Social Cognitive Theory and Self-Efficacy

Albert Bandura’s Social Cognitive Theory underscores self-efficacy—the subjective conviction that one can execute behaviors required to achieve a desired outcome—as a fundamental driver of health behavior. Patients who believe that pain is unalterable, that analgesics inevitably cause lethal addiction, or that they lack personal control exhibit low self-efficacy. This psychological state engenders passive coping strategies, treatment non-adherence, and fatalistic resignation. The PPQ measures self-efficacy directly through its control and future expectations items, while tracing its cognitive precursors across the knowledge items.

3. Ferrell’s Quality of Life Model and “Pain as a Metaphor”

In extensive qualitative and empirical studies, Betty Ferrell established that for cancer patients and their families, pain serves as a potent metaphor for illness, recurrence, and impending death. Pain disrupts four primary domains of quality of life:

1. Physical Well-Being: Sleep disruption, fatigue, impaired mobility, and nausea.
2. Psychological Well-Being: Anxiety, depression, loss of control, and anticipatory dread.
3. Social Concerns: Altered role function, isolation, and perceived burden on family caregivers.
4. Spiritual Meaning: Existential despair, theological crises, and confrontation with mortality.

The PPQ reflects this systemic view by integrating patient sensory ratings with items quantifying family distress, prognostic fears, and holistic non-pharmacological modalities.

Validity

The Patient Pain Questionnaire has been subjected to empirical psychometric evaluations across multiple inpatient, outpatient, and home hospice cancer cohorts.

Content Validity

Initial content validation was conducted by submitting the instrument to an expert panel comprising oncology clinical nurse specialists, board-certified palliative medicine physicians, pain research pharmacologists, and behavioral scientists. The panel evaluated each item for clinical relevance, clarity, construct representativeness, and freedom from technical jargon. The resulting Content Validity Index (CVI) was .95, indicating near-unanimous expert agreement on the relevance of the 16 items for evaluating adult cancer pain management.

Construct and Discriminant Validity

Construct validity has been verified across multiple comparative and experimental designs:

• Known-Groups Comparisons: The PPQ successfully differentiates between patients receiving structured oncology palliative consultations and those receiving standard care without specialized symptom management. Patients exposed to pain education programs demonstrate significantly lower misconception scores (higher knowledge) and higher perceived pain control compared to non-intervention controls (p < .001).
• Intervention Sensitivity: Longitudinal studies implementing the City of Hope Pain Education Program revealed that the PPQ is highly sensitive to educational and clinical change over time. Following a targeted educational curriculum, patient knowledge scores improved significantly, which correlated with subsequent reductions in pain intensity and distress (Ferrell et al., 1993, 1994).
• Convergent Validity: The PPQ Experience subscale demonstrates robust positive correlations with validated external pain instruments, including the Brief Pain Inventory (BPI) Worst Pain and Average Pain indices (r = .68 to .74, p < .001) and the Visual Analog Scale for Pain (VAS-P). The distress items within the Experience subscale correlate significantly with the Hospital Anxiety and Depression Scale (HADS) anxiety subscale (r = .52, p < .01).

Reliability

The reliability of the PPQ has been demonstrated across diverse patient cohorts suffering from hematologic malignancies, solid tumors, and geriatric pain syndromes.

Internal Consistency

In the primary psychometric validation study involving oncology patients and their caregivers (N = 219), the overall Patient Pain Questionnaire achieved an internal consistency reliability estimate of Cronbach’s alpha = .74. Given that the tool intentionally merges two conceptually distinct domains (cognitive knowledge/attitudes versus affective/sensory pain severity), this level of alpha reflects solid coherence without excessive item redundancy. Subscale-specific analyses routinely yield:

• Knowledge Subscale: Cronbach’s alpha ranges between .70 and .76 across home-care and hospital-based studies.
• Experience Subscale: Cronbach’s alpha ranges between .73 and .81, reflecting strong inter-item covariance among sensory intensity, distress, and relief parameters.

Test-Retest Stability

Test-retest reliability was established over short observation intervals in clinically stable oncology cohorts, yielding a Pearson correlation coefficient of r = .65 (p < .001). In chronic and progressive palliative contexts, perfect test-retest concordance is neither expected nor theoretically desirable, as acute pain flares, disease progression, and therapeutic titration introduce true biological and psychological variance. A stability coefficient of .65 confirms that the instrument’s structural traits remain steady while retaining sensitivity to actual clinical changes.

Factor Analysis

The structural composition of the PPQ was evaluated via exploratory factor analysis (EFA) using principal axis factoring with varimax and oblimin rotations on an empirical dataset comprising 219 participants (patients and related primary family caregivers assessed across clinical trials).

Factor Extraction and Loadings

Factor retention criteria (eigenvalues > 1.0 and examination of Cattell’s scree plot) clearly supported a two-factor solution accounting for substantial total variance:

• Factor 1: Analgesic Knowledge and Attitudinal Barriers (Knowledge): Items 1 through 9 loaded heavily onto this factor (loadings ranging from .42 to .78). The highest loadings were observed for items assessing addiction vulnerability, non-scheduled PRN administration beliefs, and fears of drug-induced respiratory suppression. Cross-loadings onto the experience factor were minimal (< .20).
• Factor 2: Phenomenological Pain Severity and Affective Distress (Experience): Items 10 through 16 loaded cleanly onto this factor (loadings ranging from .51 to .84). Items assessing current pain, past week pain, personal distress, and perceived family distress demonstrated the strongest loadings. Perceived control and expected future pain loaded inversely on this factor, supporting their role as protective psychological buffers.

Subsequent confirmatory studies examining dyadic caregiver and patient datasets have corroborated this two-factor model, confirming that cognitive knowledge and experiential pain distress function as distinct, though dynamically linked, psychometric constructs.

Instrument / Measurement Tool

The operational characteristics and administration specifications of the Patient Pain Questionnaire are summarized below:

• Instrument Name: Patient Pain Questionnaire (PPQ)
• Alternative Formats: Spanish version (Cuestionario Sobre el Dolor del Paciente); companion caregiver version (Family Pain Questionnaire [FPQ]).
• Measurement Format: 16-item paper-and-pencil, interviewer-administered, or digitally formatted self-report questionnaire.
• Target Population: Adult cancer patients experiencing acute or chronic malignant pain; adaptable to non-cancer chronic palliative conditions.
• Completion Time: Approximately 5 to 10 minutes.
• Response Modality: 11-point ordinal scale (numbered 0 to 10) anchored by polar conceptual endpoints tailored to each question statement.
• Directionality and Standardization: All items are formatted such that 0 represents the most positive outcome (optimal knowledge, absence of pain/distress) and 10 represents the most negative outcome (severe misconception, maximal pain/distress).
• Scoring Procedures:
  • Item Directionality Alignment: Items phrased positively (e.g., item 1 regarding pain relief efficacy, or item 5 regarding around-the-clock scheduling) are scored such that full agreement is anchored at 0 and disagreement at 10. Conversely, items framed around common myths (e.g., addiction inevitability, fatal respiratory depression) anchor agreement at 10 and disagreement at 0.
  • Knowledge Subscale Score: Mean or sum of items 1 through 9 (range: 0 to 90 for sum score; 0 to 10 for mean score).
  • Experience Subscale Score: Mean or sum of items 10 through 16 (range: 0 to 70 for sum score; 0 to 10 for mean score).
  • Total PPQ Score: Cumulative sum of all 16 items (range: 0 to 160) or grand mean across items (0 to 10).
  • Clinical Interpretation: Higher scores reflect poorer clinical status—denoting more pervasive knowledge deficits, greater analgesic fears, higher pain severity, and more severe psychosocial distress. Individual item scores $ge 5$ highlight immediate targets for patient re-education and clinical counseling.

Permissions & Fee and Test Year

The Patient Pain Questionnaire was initially developed and published between 1991 and 1993 through clinical research initiatives sponsored by the National Cancer Institute and the City of Hope National Medical Center. In alignment with the educational mission of the City of Hope Pain & Palliative Care Resource Center, Dr. Betty R. Ferrell and her co-investigators established the PPQ as an open-access, non-proprietary instrument.

Researchers, clinical oncology units, and palliative healthcare professionals are granted explicit permission to duplicate, administer, and translate the PPQ without royalty fees or licensing costs for non-commercial educational, clinical, and scientific endeavors. Proper academic citation of the original source publications (e.g., Ferrell et al., 1991, 1993) is requested in all scholarly publications, clinical protocols, and grant reports.

References

Ferrell, B. R., Borneman, T., & Juarez, G. (1998). Integration of pain education in home care. Journal of Palliative Care, 14(3), 62–68. https://doi.org/10.1177/082585979801400312

Ferrell, B. R., Cohen, M. Z., Rhiner, M., & Rozek, A. (1991). Pain as a metaphor for illness. Part II: Family caregivers’ management of pain. Oncology Nursing Forum, 18(8), 1315–1321.

Ferrell, B. R., Ferrell, B. A., Ahn, C., & Tran, K. (1994). Pain management for elderly patients with cancer at home. Cancer, 74(S7), 2139–2146. https://doi.org/10.1097/00129191-199910000-00002

Ferrell, B. R., & Rivera, L. M. (1997). Cancer pain education for patients. Seminars in Oncology Nursing, 13(1), 42–48. https://doi.org/10.1016/s0749-2081(97)80048-9

Ferrell, B. R., Rhiner, M., Cohen, M. Z., & Grant, M. (1991). Pain as a metaphor for illness. Part I: Impact of cancer pain on family caregivers. Oncology Nursing Forum, 18(8), 1303–1309.

Ferrell, B. R., Rhiner, M., & Ferrell, B. A. (1993). Development and implementation of a pain education program. Cancer, 72(11), 3426–3432. https://doi.org/10.1126/science.150.3699.971

Items of the Scale